Search research articles
Contact Us
Filters
Showing results (31-40 of 359) with videos related to
Page
of 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2011
Estrogen receptor: a never ending story?
Antonio C Wolff, Mitch Dowsett
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer
Mitch Dowsett, Anita K Dunbier
Recent Progress in Hormone Research
|
May 23, 2002
Aromatase and its inhibitors: significance for breast cancer therapy
Evan R Simpson, Mitch Dowsett
Steroids
|
March 19, 2011
10th International Aromatase Conference Proceedings, September 2010. Preface
Mitch Dowsett, Per Eystein Lonning
Endocrine-Related Cancer
|
July 22, 2010
Current and emerging biomarkers in breast cancer: prognosis and prediction
Marion T Weigel, Mitch Dowsett
Cancer Cell
|
July 13, 2013
BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer?
Lesley-Ann Martin, Mitch Dowsett
The New England Journal of Medicine
|
June 13, 2003
Aromatase inhibitors in breast cancer
Ian E Smith, Mitch Dowsett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2011
Presurgical progesterone in early breast cancer: so much for so little?
Mitch Dowsett, Ian E Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2014
Estrogen receptor mutations in breast cancer--new focus on an old target
Corrinne V Segal, Mitch Dowsett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2010
Endocrine effects of aromatase inhibitors
Per E Lønning, Mitch Dowsett
Page
of 36
Search research articles
Search
Showing results (31-40 of 359) with videos related to
Sort By:
Page
of 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2011
Estrogen receptor: a never ending story?
Antonio C Wolff, Mitch Dowsett
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer
Mitch Dowsett, Anita K Dunbier
Recent Progress in Hormone Research
|
May 23, 2002
Aromatase and its inhibitors: significance for breast cancer therapy
Evan R Simpson, Mitch Dowsett
Steroids
|
March 19, 2011
10th International Aromatase Conference Proceedings, September 2010. Preface
Mitch Dowsett, Per Eystein Lonning
Endocrine-Related Cancer
|
July 22, 2010
Current and emerging biomarkers in breast cancer: prognosis and prediction
Marion T Weigel, Mitch Dowsett
Cancer Cell
|
July 13, 2013
BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer?
Lesley-Ann Martin, Mitch Dowsett
The New England Journal of Medicine
|
June 13, 2003
Aromatase inhibitors in breast cancer
Ian E Smith, Mitch Dowsett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2011
Presurgical progesterone in early breast cancer: so much for so little?
Mitch Dowsett, Ian E Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2014
Estrogen receptor mutations in breast cancer--new focus on an old target
Corrinne V Segal, Mitch Dowsett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 21, 2010
Endocrine effects of aromatase inhibitors
Per E Lønning, Mitch Dowsett
Page
of 36